story of the week
Incidence and Management of CAR-T Neurotoxicity in Patients With Multiple Myeloma Treated With Ciltacabtagene Autoleucel
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies
Blood Cancer J 2022 Feb 24;12(2)32, AD Cohen, S Parekh, BD Santomasso, J Gállego Pérez-Larraya, NWCJ van de Donk, B Arnulf, MV Mateos, N Lendvai, CC Jackson, KC De Braganca, JM Schecter, L Marquez, E Lee, I Cornax, E Zudaire, C Li, Y Olyslager, D Madduri, H Varsos, L Pacaud, M Akram, D Geng, A Jakubowiak, H Einsele, S JagannathFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.